Welcome to the Letai Lab: Targeting Cancer Cell Death
Our lab devises methods to selectively kill cancer cells by better understanding apoptotic cell death
Alongside the lab's mission, Dr Anthony Letai is also the president of The Society for Functional Precision Medicine, which works to improve patient care and outcomes by facilitating implementation of functional assays into clinical care.
Our Bulletin Board
Congratulations to Thelma Mashaka on her Ph.D. from Icahn School of Medicine at Mt Sinai!
Letai Lab graduate Lara Bencsics proudly representing us in the Dominican Republic!
Trying to kill senescent cells?
Jason Wu, Cole Turner, Dr. Anthony Letai, Jeremy Ryan, Shaili Soni, and Maria Davern showing their Halloween spirit at a staff Halloween gathering.
Will Sanborn and Letai Lab's Jeremy Ryan out on the Jimmy Fun Walk course on October 6th taking on the full 26.2 mile Boston Marathon route. The Jimmy Fund Walk helps raise funds for patient care and research.
The researchers highlighted the effectiveness of a functional precision medicine approach, called dynamic BH3 profiling (DBP), in identifying targeted therapy for highly aggressive relapsed acute myeloid leukemia. The technique can measure the increase in mitochondrial priming, which signifies a higher potential for apoptosis.
